Fundraising FoxRapid Micro Biosystems
NASDAQ: RPIDLowell, US · Delaware corporation · 5 known investors
Find your way into Rapid Micro Biosystems
Sign up to see every warm intro you have to Rapid Micro Biosystems
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rapid Micro Biosystems team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Rapid Micro Biosystems manufactures automated laboratory testing systems and consumables for pharmaceutical and cell therapy manufacturers to conduct microbiological quality control testing, replacing manual methods with platform-based analysis.
Founders & leadership
Board
Investors · 5
How we know: funding news · Not right? Tell us
How we know: Kleiner Perkins's portfolio page · Not right? Tell us
How we know: Longitude Capital's portfolio page · Not right? Tell us
How we know: Xeraya Capital's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$90.7M disclosed across 4 of 5 rounds · 2014–2020
▶$60MraisedAug 2019 · 11 investors · Other Health CareRule 506(b)
- BRUCE COHENDirector
- NATALE RICCIARDIDirector
- SEAN WIRTJESExecutive Officer
- JEFFREY SCHWARTZDirector
- DAVID HIRSCHDirector
- CHRISTOPHER CASHMANDirector
- RICHARD KOLLENDERDirector
- ROBERT SPIGNESIExecutive Officer, Director
- Offering amount
- $60M
- Amount sold
- $60M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18.7MraisedMay 2015 · 18 investors · Other Health CareRule 506(b)
- Richard S. KollenderDirector
- David HirschDirector
- Robert SpignesiExecutive Officer, Director
- Tom MonathDirector
- Christopher M. CashmanDirector
- Fred CohenDirector
- Amount sold
- $18.7M
- First sale
- Apr 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedMar 2015 · 6 investors · Other Health CareRule 506(b)
- David HirschDirector
- Tom MonathDirector
- Christopher M. CashmanDirector
- Richard S. KollenderDirector
- Robert SpignesiExecutive Officer, Director
- Fred CohenDirector
- Amount sold
- $6M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedApr 2014 · 9 investors · Other Health CareRule 506(b)
- Christopher M. CashmanDirector
- Stephen H. DelityExecutive Officer, Director
- David HirschDirector
- Tom MonathDirector
- Fred CohenDirector
- Michael J. MullenExecutive Officer
- Richard S. KollenderDirector
- Amount sold
- $6M
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Founder mafia
2 people who came through Rapid Micro Biosystems went on to found or lead other companies.
Frequently asked questions
- What does Rapid Micro Biosystems do?
- Rapid Micro Biosystems manufactures automated laboratory testing systems and consumables for pharmaceutical and cell therapy manufacturers to conduct microbiological quality control testing, replacing manual methods with platform-based analysis.
- Who are Rapid Micro Biosystems's investors?
- Rapid Micro Biosystems's investors include Endeavour Vision, Kleiner Perkins, Longitude Capital, Xeraya Capital, Ally Bridge Group.
- How much funding has Rapid Micro Biosystems raised?
- Rapid Micro Biosystems has disclosed $90.7M raised across 4 of its 5 known rounds.
- Where is Rapid Micro Biosystems headquartered?
- Rapid Micro Biosystems is headquartered in Lowell, US.